Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.93−0.08 (-3.98%)
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
Ernexa Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Ernexa Therapeutics's profit margin for the twelve months ending Dec 31, 2024 was -7652.7%. For fiscal 2024 it was -7652.7%, against -31864.7% the year before. The highest annual figure on record is -1.1% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -7652.7% | +24212.0 |
| FY2023 | Dec 31, 2023 | -31864.7% | −31739.0 |
| FY2020 | Dec 31, 2020 | -125.7% | −115.4 |
| FY2019 | Dec 31, 2019 | -10.3% | −9.2 |
| FY2018 | Dec 31, 2018 | -1.1% | +4.0 |
| FY2017 | Dec 31, 2017 | -5.1% | +8.0 |
| FY2016 | Dec 31, 2016 | -13.1% | +16.4 |
| FY2015 | Dec 31, 2015 | -29.5% | −10.2 |
| FY2014 | Dec 31, 2014 | -19.3% | −14.9 |
| FY2013 | Dec 31, 2013 | -4.4% | −0.3 |
| FY2012 | Dec 31, 2012 | -4.1% | +10.2 |
| FY2011 | Dec 31, 2011 | -14.3% | −12.7 |
| FY2010 | Dec 31, 2010 | -1.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -575900.0% | −539705.9 |
| Q3 FY2024 | Sep 30, 2024 | -5462.8% | +5499.9 |
| Q2 FY2024 | Jun 30, 2024 | -11763.8% | −11575.0 |
| Q1 FY2024 | Mar 31, 2024 | -14142.6% | −14005.8 |
| Q4 FY2023 | Dec 31, 2023 | -36194.1% | −35924.4 |
| Q3 FY2023 | Sep 30, 2023 | -10962.7% | −10920.2 |
| Q4 FY2020 | Dec 31, 2020 | -188.8% | −163.8 |
| Q3 FY2020 | Sep 30, 2020 | -136.8% | −129.1 |
| Q2 FY2020 | Jun 30, 2020 | -269.7% | −268.0 |
| Q1 FY2020 | Mar 31, 2020 | -42.6% | −36.1 |
| Q4 FY2019 | Dec 31, 2019 | -25.0% | −25.9 |
| Q3 FY2019 | Sep 30, 2019 | -7.7% | −11.4 |
| Q2 FY2019 | Jun 30, 2019 | -1.7% | +0.5 |
| Q1 FY2019 | Mar 31, 2019 | -6.5% | +0.6 |
| Q4 FY2018 | Dec 31, 2018 | 0.9% | +12.9 |
| Q3 FY2018 | Sep 30, 2018 | 3.7% | +7.2 |
| Q2 FY2018 | Jun 30, 2018 | -2.2% | +0.8 |
| Q1 FY2018 | Mar 31, 2018 | -7.1% | −5.4 |
| Q4 FY2017 | Dec 31, 2017 | -12.1% | −4.4 |
| Q3 FY2017 | Sep 30, 2017 | -3.5% | – |
| Q2 FY2017 | Jun 30, 2017 | -3.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -1.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -7.7% | – |
See a number that looks wrong?